Noninvasive ventilation for patients with acute lung injury or acute respiratory distress syndrome

Stefano Nava, Ania Schreiber, Guido Domenighetti

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Few studies have been performed on noninvasive ventilation (NIV) to treat hypoxic acute respiratory failure in patients with acute lung injury (ALI) or acute respiratory distress syndrome (ARDS). The outcomes of these patients, for whom endotracheal intubation is not mandatory, depend on the degree of hypoxia, the presence of comorbidities and complications, and their illness severity. The use of NIV as an alternative to invasive ventilation in severely hypoxemic patients with ARDS (ie, P aO2 /F IO2 <200) is not generally advisable and should be limited to hemodynamically stable patients who can be closely monitored in an intensive care unit by highly skilled staff. Early NIV application may be extremely helpful in immunocompromised patients with pulmonary infiltrates, in whom intubation dramatically increases the risk of infection, pneumonia, and death. The use of NIV in patients with severe acute respiratory syndrome and other airborne diseases has generated debate, despite encouraging clinical results, mainly because of safety issues. Overall, the high rate of NIV failure suggests a cautious approach to NIV use in patients with ALI/ARDS, including early initiation, intensive monitoring, and prompt intubation if signs of NIV failure emerge.

Original languageEnglish
Pages (from-to)1583-1588
Number of pages6
JournalRespiratory Care
Volume56
Issue number10
DOIs
Publication statusPublished - Oct 2011

Fingerprint

Noninvasive Ventilation
Acute Lung Injury
Adult Respiratory Distress Syndrome
Intubation
Severe Acute Respiratory Syndrome
Intratracheal Intubation
Immunocompromised Host
Respiratory Insufficiency
Intensive Care Units
Ventilation
Comorbidity
Pneumonia
Safety
Lung
Infection

Keywords

  • Acute lung injury
  • Acute respiratory distress syndrome
  • ALI
  • ARDS
  • Intubation
  • NIV
  • Noninvasive ventilation

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Noninvasive ventilation for patients with acute lung injury or acute respiratory distress syndrome. / Nava, Stefano; Schreiber, Ania; Domenighetti, Guido.

In: Respiratory Care, Vol. 56, No. 10, 10.2011, p. 1583-1588.

Research output: Contribution to journalArticle

Nava, Stefano ; Schreiber, Ania ; Domenighetti, Guido. / Noninvasive ventilation for patients with acute lung injury or acute respiratory distress syndrome. In: Respiratory Care. 2011 ; Vol. 56, No. 10. pp. 1583-1588.
@article{d0444cec4d51421abb48e797be43a00d,
title = "Noninvasive ventilation for patients with acute lung injury or acute respiratory distress syndrome",
abstract = "Few studies have been performed on noninvasive ventilation (NIV) to treat hypoxic acute respiratory failure in patients with acute lung injury (ALI) or acute respiratory distress syndrome (ARDS). The outcomes of these patients, for whom endotracheal intubation is not mandatory, depend on the degree of hypoxia, the presence of comorbidities and complications, and their illness severity. The use of NIV as an alternative to invasive ventilation in severely hypoxemic patients with ARDS (ie, P aO2 /F IO2 <200) is not generally advisable and should be limited to hemodynamically stable patients who can be closely monitored in an intensive care unit by highly skilled staff. Early NIV application may be extremely helpful in immunocompromised patients with pulmonary infiltrates, in whom intubation dramatically increases the risk of infection, pneumonia, and death. The use of NIV in patients with severe acute respiratory syndrome and other airborne diseases has generated debate, despite encouraging clinical results, mainly because of safety issues. Overall, the high rate of NIV failure suggests a cautious approach to NIV use in patients with ALI/ARDS, including early initiation, intensive monitoring, and prompt intubation if signs of NIV failure emerge.",
keywords = "Acute lung injury, Acute respiratory distress syndrome, ALI, ARDS, Intubation, NIV, Noninvasive ventilation",
author = "Stefano Nava and Ania Schreiber and Guido Domenighetti",
year = "2011",
month = "10",
doi = "10.4187/respcare.01209",
language = "English",
volume = "56",
pages = "1583--1588",
journal = "Respiratory Care",
issn = "0020-1324",
publisher = "by Daedalus Enterprises",
number = "10",

}

TY - JOUR

T1 - Noninvasive ventilation for patients with acute lung injury or acute respiratory distress syndrome

AU - Nava, Stefano

AU - Schreiber, Ania

AU - Domenighetti, Guido

PY - 2011/10

Y1 - 2011/10

N2 - Few studies have been performed on noninvasive ventilation (NIV) to treat hypoxic acute respiratory failure in patients with acute lung injury (ALI) or acute respiratory distress syndrome (ARDS). The outcomes of these patients, for whom endotracheal intubation is not mandatory, depend on the degree of hypoxia, the presence of comorbidities and complications, and their illness severity. The use of NIV as an alternative to invasive ventilation in severely hypoxemic patients with ARDS (ie, P aO2 /F IO2 <200) is not generally advisable and should be limited to hemodynamically stable patients who can be closely monitored in an intensive care unit by highly skilled staff. Early NIV application may be extremely helpful in immunocompromised patients with pulmonary infiltrates, in whom intubation dramatically increases the risk of infection, pneumonia, and death. The use of NIV in patients with severe acute respiratory syndrome and other airborne diseases has generated debate, despite encouraging clinical results, mainly because of safety issues. Overall, the high rate of NIV failure suggests a cautious approach to NIV use in patients with ALI/ARDS, including early initiation, intensive monitoring, and prompt intubation if signs of NIV failure emerge.

AB - Few studies have been performed on noninvasive ventilation (NIV) to treat hypoxic acute respiratory failure in patients with acute lung injury (ALI) or acute respiratory distress syndrome (ARDS). The outcomes of these patients, for whom endotracheal intubation is not mandatory, depend on the degree of hypoxia, the presence of comorbidities and complications, and their illness severity. The use of NIV as an alternative to invasive ventilation in severely hypoxemic patients with ARDS (ie, P aO2 /F IO2 <200) is not generally advisable and should be limited to hemodynamically stable patients who can be closely monitored in an intensive care unit by highly skilled staff. Early NIV application may be extremely helpful in immunocompromised patients with pulmonary infiltrates, in whom intubation dramatically increases the risk of infection, pneumonia, and death. The use of NIV in patients with severe acute respiratory syndrome and other airborne diseases has generated debate, despite encouraging clinical results, mainly because of safety issues. Overall, the high rate of NIV failure suggests a cautious approach to NIV use in patients with ALI/ARDS, including early initiation, intensive monitoring, and prompt intubation if signs of NIV failure emerge.

KW - Acute lung injury

KW - Acute respiratory distress syndrome

KW - ALI

KW - ARDS

KW - Intubation

KW - NIV

KW - Noninvasive ventilation

UR - http://www.scopus.com/inward/record.url?scp=82455186256&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82455186256&partnerID=8YFLogxK

U2 - 10.4187/respcare.01209

DO - 10.4187/respcare.01209

M3 - Article

C2 - 22008399

AN - SCOPUS:82455186256

VL - 56

SP - 1583

EP - 1588

JO - Respiratory Care

JF - Respiratory Care

SN - 0020-1324

IS - 10

ER -